IMFINZI

Manufacturer:

Astrazeneca

Name:

IMFINZI

HCPCS Code Descriptor:

Injection, durvalumab, 10 mg

Category:

J Code

HCPCS:

J9173

NDC(s):

00310-4611-50, 00310-4500-12

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

IMFINZI is an Oncology drug manufactured by Astrazeneca and administered via the Intravenous route of administration. The J Code: J9173 is aligned to the drug IMFINZI.

Imfinzi works by blocking a protein on the surface of cancer cells called PD-L1. Imfinzi is administered via intravenous infusion over a one-hour time frame. Imfinzi was previously aligned to the temporary HCPCS C9492 before receiving the permanent HCPCS J9173. Patient support for this medication can be found through the Astrazeneca Pharmaceuticals AZ & Me prescription savings program and others.